These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15005535)

  • 21. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
    Daniels LB; Barrett-Connor E
    J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
    [No Abstract]   [Full Text] [Related]  

  • 23. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Troughton RW; Richards AM; Yandle TG; Nicholls G
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232832
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experiences with serum BNP (B type natriuretic peptide) in patients with systolic and diastolic heart failure].
    Lukács I; Fey E; Kárpáti P
    Orv Hetil; 2005 Sep; 146(37):1919-23. PubMed ID: 16255376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
    Pimenta JM; Almeida R; Araújo JP; Azevedo A; Friões F; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    J Card Fail; 2007 May; 13(4):275-80. PubMed ID: 17517347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
    Rutten JH; Boomsma F; Van den Meiracker AH
    Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2553-7. PubMed ID: 18074722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in heart failure. Does prognostic utility translate to clinical futility?
    Maisel A
    J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715
    [No Abstract]   [Full Text] [Related]  

  • 29. Biomarkers in heart failure management.
    Isaac DL
    Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?
    Rodeheffer RJ
    J Am Coll Cardiol; 2004 Aug; 44(4):740-9. PubMed ID: 15312852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
    Masson S; Latini R; Anand IS; Barlera S; Angelici L; Vago T; Tognoni G; Cohn JN;
    J Am Coll Cardiol; 2008 Sep; 52(12):997-1003. PubMed ID: 18786480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical applications of brain natriuretic peptide testing].
    Scardovi AB; ; ; ; ;
    Ital Heart J Suppl; 2004 May; 5(5):343-56. PubMed ID: 15182061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine.
    Bertinchant JP; Combes N; Polge A; Fabbro-Peray P; Raczka F; Beck L; Cade S; Ledermann B
    Clin Chim Acta; 2005 Feb; 352(1-2):143-53. PubMed ID: 15653109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure.
    Cortés R; Rivera M; Salvador A; García de Burgos F; Bertomeu V; Roselló-Lletí E; Martínez-Dolz L; Payá R; Almenar L; Portolés M
    J Card Fail; 2007 Sep; 13(7):549-55. PubMed ID: 17826645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients].
    Shao YH; Lai YQ; Lin AZ; Kong YZ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):892-4. PubMed ID: 16027094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptide assays for detecting heart failure in the elderly: same value as those in the younger?
    Rutten FH; Hoes AW
    Int J Cardiol; 2008 Apr; 125(2):161-5. PubMed ID: 17963872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial measurements of plasma B-type natriuretic peptides: what do they tell us?
    Richards AM
    J Am Coll Cardiol; 2008 Sep; 52(12):1004-5. PubMed ID: 18786481
    [No Abstract]   [Full Text] [Related]  

  • 39. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
    Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
    Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.